CIPLA:NSE
Cipla Ltd
₹1,342.40
arrow_upward
+0.52%(+6.90) 1D
Okt 6, 3:30:00 PM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa CIPLA...
Buksan
₹1,335.00
Mataas
₹1,344.90
Mababa
₹1,323.20
Mkt. cap
1.09T
Avg. na dami
936.55K
Dami
575.70K
Dividend
0.97%
Bawat tatlong buwang dividend
₹3.25
Petsa ng ex-dividend
Hun 5, 2026
P/E ratio
32.19
Mataas nang 52-wk
₹1,673.00
Mababa nang 52-wk
₹1,165.70
EPS
₹41.70
Mga natitirang share
805.67M
Bilang ng mga empleyado
31K
Buksan
₹1,335.00
Mataas
₹1,344.90
Mababa
₹1,323.20
Mkt. cap
1.09T
Avg. na dami
936.55K
Dami
575.70K
Dividend
0.97%
Bawat tatlong buwang dividend
₹3.25
Petsa ng ex-dividend
Hun 5, 2026
P/E ratio
32.19
Mataas nang 52-wk
₹1,673.00
Mababa nang 52-wk
₹1,165.70
EPS
₹41.70
Mga natitirang share
805.67M
Bilang ng mga empleyado
31K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
The Guardian
·
6 oras ang nakalipas
S&P 500 and Nasdaq surge to record highs after AI chipmaker rally
investingLive
·
6 oras ang nakalipas
investingLive Americas FX news wrap 6 Oct: S&P/Nasdaq set records as oil rebounds and the U.S. trade deficit widens
MarketWatch
·
4 araw ang nakalipas
The stock market is anything but normal right now — and these charts show it
Bloomberg.com
·
1 linggo ang nakalipas
Stocks and Bonds Pause Ahead of US Data, Micron: Markets Wrap
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
Tungkol sa Cipla Ltd
CEOUmang Vohra
Mga Empleyado31.4K
Itinatag1935
HeadquartersMumbai, Maharashtra, India
Sektor-
Websitecipla.com